Status:
COMPLETED
Impact of Electrolyte Intake (Sodium, Phosphorus) on the Growth of Premature Newborns
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Postnatal Growth Disorder
Eligibility:
All Genders
1-30 years
Brief Summary
Extrauterine growth restriction (EUGR) is a common complication in the medical management of premature newborns. The long-term consequences of EUGR are weight and height restriction, metabolic disorde...
Eligibility Criteria
Inclusion
- Neonates born between January 1st 2023 and December 31st 2023
- Neonates born before 37 SA
- Neonates hospitalized at the Nancy Maternity Hospital in Neonatology
Exclusion
- Neonates transferred at the Nancy Maternity Hospital after 48 first hours of life
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
684 Patients enrolled
Trial Details
Trial ID
NCT06506981
Start Date
January 1 2023
End Date
June 30 2024
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternity Hospital CHRU
Nancy, Lorraine, France, 54035